Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › platelet-rich plasma (PRP)

platelet-rich plasma (PRP)

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of platelet-rich plasma (PRP)

3 trials tracked of platelet-rich plasma (PRP).

3Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 1 1 Other / NA 2
  1. Phase 1 Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction Completed
  2. N/A Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee Completed
  3. N/A Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Exosomes are safe for knee osteoarthritis but show no superiority over placebo in one trial
Anesthesiology & Pain Medicine Sys. Review
Exosomes are safe for knee osteoarthritis but show no superiority over placebo in one trial Exosomes for knee arthritis: safe but no better than placebo
This systematic scoping review synthesizes evidence on orthobiologics including platelet-rich plasma, cytokine-rich serum, and extracellular…
A review finds exosome injections for knee osteoarthritis are safe, but one trial shows no advantage over placebo.
Frontiers Aug 17, 2026
PRP growth factors converge on PI3K–AKT and MAPK pathways in ovarian follicular development
OB/GYN & Women's Health Sys. Review
PRP growth factors converge on PI3K–AKT and MAPK pathways in ovarian follicular development PRP may boost ovarian signaling pathways, study finds
A systematic mechanistic review and computational pathway analysis found that growth factors in platelet-rich plasma (PRP) converge on PI3K–…
A computational analysis suggests PRP may activate key ovarian signaling pathways, but does not replace natural follicle development.
Frontiers Jul 30, 2026